Markets Review

Sources: CAPS CompositeHubTM, Bloomberg
Past performance is not indicative of future results. Aristotle Value Equity Composite returns are presented gross and net of model fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are calculated by subtracting a model fee of 0.50% on an annual basis or 0.04167% on a monthly basis, which includes trading costs and the reinvestment of all income. Please see important disclosures at the end of this document.

Breakdowns in geopolitical negotiations, changes in central bank policy and renewed trade conflicts; we’ve seen it all before. Concentrated capital, driven by speculative enthusiasm and drawing attention away from fundamentally stable, predictable businesses; we’ve spoken about this at length.

More recently, significant changes in the composition of our primary benchmark, the Russell 1000 Value, have reshaped the Index. Seven of the Index’s ten largest contributors to returns during the first half of the year were removed at the end of June: Micron, Caterpillar, Applied Materials, AMD, Sandisk, Western Digital and Marvell Technology. At the same time, Apple and Microsoft entered the Index, while Amazon’s weight increased significantly. Together, Amazon, Apple and Microsoft represented approximately 15% of the benchmark following the reconstitution, compared with approximately 10% for the Index’s three largest constituents at the end of 2025.

The impact extends beyond individual constituents. The sector composition of the Russell 1000 Value has also changed meaningfully since late last year, with Information Technology increasing from approximately 12% of the Index to 21%, while Communication Services declined from approximately 8% to 3%. As a result, the exposures represented by the Index today are materially different from those represented by the same benchmark less than a year ago (and increasingly reminiscent of growth indexes of the past).

These changes have occurred during a period of unusually wide dispersion between high- and low-beta stocks. Over the past six months ending September 30, the highest-beta quintile of the Russell 1000 Value gained approximately 53%, while the lowest-beta quintile declined approximately 2%, a spread of about 55 percentage points. Beta, not simply value exposure, was therefore a major driver of relative returns during this period. For long-term investors, a value rally driven by higher beta can mask greater market risk, as higher returns may reflect greater market sensitivity rather than improving fundamentals.

Concentrated Leadership Has Reached Value Benchmarks

1For purposes of this analysis, “narrower participation” refers to periods in which a relatively sm1all number of securities account for a disproportionate share of an index’s total return.

While these dynamics help explain recent relative performance, we believe the more important forward-looking questions for long-term investors are, “What unintended risks have these dislocations created?” and “Where do the most attractive opportunities exist today?” Many of Value Equity’s recent detractors have continued to grow earnings even as their valuation multiples have compressed, resulting in an increasingly attractive disconnect between fundamentals and share prices.

Performance and Attribution Summary

For the third quarter of 2026, Aristotle Capital’s Value Equity Composite posted a total return of 0.37% gross of fees (0.25% net of fees), underperforming the 2.61% return of the Russell 1000 Value Index and the 2.30% return of the S&P 500 Index. Please refer to the table for detailed performance.

Performance (%) 3Q26YTD1 Year3 Years5 Years10 Years
Value Equity Composite (gross)0.372.724.2012.486.6811.42
Value Equity Composite (net)0.252.333.6811.926.1510.87
Russell 1000 Value Index2.6119.2723.8120.0711.9211.43
S&P 500 Index2.3012.7515.7422.8913.7915.33
Past performance is not indicative of future results. Aristotle Value Equity Composite returns are presented gross and net of model fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of model fees. Net returns are calculated by subtracting a model fee of 0.50% on an annual basis or 0.04167% on a monthly basis, which includes trading costs and the reinvestment of all income. Please see important disclosures at the end of this document.

Source: FactSet
Past performance is not indicative of future results. Sector attribution shows how much of a portfolio’s overall return is directly attributable to stock selection and asset allocation decisions within the portfolio, highlighting which sectors contributed or detracted to the total return. Attribution includes the reinvestment of income. Attribution is presented gross of fees and does not include the deduction of all fees and expenses that a client or investor has paid or would have paid. Please refer to the gross and net composite returns included within to understand the overall impact of fees

The portfolio’s underperformance relative to the Russell 1000 Value Index in the third quarter can be attributed to both security selection and allocation effects. Security selection in Information Technology, Materials and Communication Services detracted the most from relative performance. Conversely, security selection in Financials, an underweight in Consumer Discretionary and an overweight in Communication Services contributed. (Relative weights are the result of bottom-up security selection.)

Contributors and Detractors for 3Q 2026

Relative ContributorsRelative Detractors
Mitsubishi UFJ FinancialMartin Marietta Materials
AmgenMicrochip Technology
SonyCorteva
ChevronCarrier Global
TotalEnergiesMicrosoft

Relative contributors and detractors are based on attribution total effect and exclude benchmark securities not held in the portfolio.

Martin Marietta, a leading supplier of construction aggregates and building materials, was the largest detractor during the quarter. Despite continued strength in the company’s underlying results, shares declined as investors remained cautious about the outlook for construction activity and the timing of a recovery in interest-rate-sensitive end markets. Martin Marietta reported record second quarter revenues, continued pricing gains and strong operating performance during the period. The company also completed the $13.5 billion acquisition of Lhoist North America, significantly expanding its higher-margin Specialties business and adding more than two billion tons of high-quality limestone reserves. The transaction also broadens Martin Marietta’s exposure to infrastructure and industrial end markets, including domestic manufacturing, data centers and energy development. We believe the company’s advantaged reserve positions, disciplined pricing and the continued shift toward higher-value upstream materials should support attractive long-term earnings and cash flow generation.

Microchip Technology, the microcontroller (MCU) and analog semiconductor producer, was a significant detractor during the period. The company’s stock sold off despite continued evidence of improvement in its underlying business. Customer inventories continued to normalize and bookings remained strong, supporting a recovery in demand following the prolonged industry downturn. Higher factory utilization and disciplined expense management also contributed to improved profitability and cash flow generation. While management noted potential capacity constraints at certain external manufacturing partners, Microchip’s internal capacity remains sufficient to support its growth expectations. We believe the company’s broad product portfolio, longstanding customer relationships and commitment to extended product lifecycles position it well to benefit from a continued recovery in its core end markets, while growing opportunities in data centers and aerospace & defense provide additional avenues for long-term growth.

Amgen, the biopharmaceutical company, was one of the largest contributors during the quarter. The company has continued to benefit from growth across several newer and expanding medicines, including Repatha (cholesterol), Evenity (osteoporosis), Tezspire (asthma) and Uplizna (rare autoimmune diseases), as well as emphasizing clinical developments across its pipeline. While Amgen faces increasing biosimilar competition for several of its mature biologic therapies, the company is also benefiting from opportunities in the growing biosimilars market. Leveraging its biologics expertise and global manufacturing scale, the company has generated more than $15 billion in biosimilar sales since 2018, with additional candidates in development. We believe the breadth of Amgen’s portfolio and improving research productivity, combined with its ability to capitalize on its global commercial and manufacturing infrastructure, position the company to benefit as its pipeline develops.

Chevron, one of the world’s largest integrated energy companies, was a leading contributor during the quarter. While higher oil prices provided a favorable backdrop, we remain more focused on the continued improvement in the underlying economics of the business. The completion of the Tengiz expansion moved a significant multi-year project from investment into production. Meanwhile, the 2025 acquisition of Hess added Guyana’s Stabroek block to Chevron’s asset portfolio, where six announced developments have breakeven costs below $35 per barrel. In addition, its Permian Basin footprint is shifting from an emphasis on production growth toward cash generation as spending moderates and operating efficiencies improve. The company also reached its $3 billion structural cost-reduction target six months ahead of schedule. Looking forward, we believe low-cost production growth from Guyana, increasing capital efficiency across the portfolio and continued operating discipline should support higher returns and FREE cash flow as the company benefits from several years of significant investment.

Recent Portfolio Activity

BuysSells
Carrier GlobalOshkosh

During the quarter, we sold our position in Oshkosh and purchased Carrier Global.

We most recently invested in Oshkosh, a manufacturer of specialty vehicles and access equipment, in early 2022. During our holding period, we believe the company executed well on many of the catalysts we had identified, including improved profitability through pricing discipline, manufacturing efficiencies, a more favorable business mix, continued product innovation and the ramp-up of production of the U.S. Postal Service’s Next Generation Delivery Vehicle program. Given the progress, we chose to sell our position and redeploy the proceeds into what we believe is a more attractive opportunity in Carrier Global.

Carrier Global Corporation

Headquartered in Florida, Carrier Global is a leading global provider of heating, ventilation and air conditioning (HVAC) solutions. The company traces its roots to Willis Carrier’s invention of modern air conditioning in 1902 and today serves residential, commercial and transportation markets around the world. Carrier holds leading positions across several HVAC categories and owns a portfolio of well-recognized brands, including Carrier, Viessmann and Transicold.

Carrier became an independent public company following its 2020 spinoff from United Technologies. Since then, management has substantially reshaped the business, divesting the company’s Fire & Security and Commercial Refrigeration operations and acquiring Viessmann Climate Solutions and Carrier’s former joint venture with Toshiba (Carrier Japan). These transactions have transformed Carrier into a more focused HVAC company with technologies spanning traditional ducted systems, ductless and mini-split systems, heat pumps, inverter-based air conditioning, and large commercial applications.

We believe the world remains structurally “under air-conditioned.” Rising global temperatures, increasing living standards, and electrification of buildings to incorporate heating and more stringent energy-efficiency requirements should support long-term demand for HVAC equipment. Importantly, we find that Carrier’s breadth of technologies and geographic reach position the company to benefit from growing HVAC demand diversified across markets and applications rather than relying on any single technology or end market.

Some of the quality characteristics we have identified for Carrier include:

  • Leading market positions across several HVAC categories, including U.S. residential and light commercial, European residential and commercial, and transport refrigeration;
  • Strong brands and distribution networks, which create meaningful barriers to entry, particularly in developed residential HVAC markets;
  • An expanding parts and service business, which provides more recurring revenue and attractive margins while deepening Carrier’s relationships with its installed customer base; and
  • A well-regarded and stable management team that has successfully repositioned Carrier into a more focused HVAC company following its separation from United Technologies.

Attractive Valuation

We believe shares of Carrier are attractively valued relative to our estimates of the company’s normalized earnings and FREE cash flow generation. In our view, the current valuation does not fully reflect the potential for residential HVAC volumes in North America and Europe to recover from depressed levels, continued market share gains in commercial HVAC, or further expansion of the company’s higher-margin aftermarket parts and service business. Carrier also generates meaningful FREE cash flow, supporting a well-covered and growing dividend while providing additional capital for share repurchases and other capital allocation opportunities.

Compelling Catalysts   

Catalysts we have identified for Carrier, which we believe will cause its stock price to appreciate over our three- to five-year investment horizon, include:

  • Increasing global air-conditioning penetration, supported by rising living standards, electrification and regulatory requirements that encourage adoption of more efficient, higher-value HVAC systems;
  • Continued expansion of Carrier’s aftermarket parts and service business, where improved capture of its installed base should contribute to more recurring revenue, higher margins and less cyclical earnings over time;
  • Market share gains in large commercial, or “applied,” HVAC, where Carrier has reinvigorated its product offering since becoming independent, with additional growth opportunities from data centers and other industrial applications requiring increasingly sophisticated cooling technologies;
  • Normalization of residential HVAC demand in North America and Europe, including European heat-pump demand, where industry volumes remain below historical levels;
  • Benefits from the Viessmann acquisition, including its strong European brand, installer network and heat-pump technology that can potentially be leveraged across Carrier’s broader geographic footprint; and
  • Continued capital deployment through a growing dividend and share repurchases, supported by meaningful FREE cash flow generation.

Conclusion

Periods of relative underperformance can test conviction, particularly when market leadership is narrow and rapidly changing. However, we believe the appropriate response is not to chase what has recently worked but to remain focused on the long-term drivers of value creation. This discipline has guided our investment process across multiple market cycles and continues to shape how we position the portfolio today.

Importantly, recent performance has not been accompanied by a deterioration in the businesses we own. In many cases, earnings have continued to grow even as valuation multiples have compressed, creating what we believe is an increasingly attractive disconnect between share prices and normalized earnings power. While periods like this are challenging, they can also create opportunity for long-term investors. We believe the very conditions that have challenged recent relative performance have strengthened the portfolio’s prospective return potential.

Disclosures

The opinions expressed herein are those of Aristotle Capital Management, LLC (Aristotle Capital) and are subject to change without notice. Past performance is not a guarantee or indicator of future results. This material is not financial advice or an offer to purchase or sell any product. You should not assume that any of the securities transactions, sectors or holdings discussed in this report were or will be profitable, or that recommendations Aristotle Capital makes in the future will be profitable or equal the performance of the securities listed in this report. The portfolio characteristics shown relate to the Aristotle Value Equity strategy. Not every client’s account will have these characteristics. Aristotle Capital reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Capital’s Value Equity Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. Recommendations made in the last 12 months are available upon request.

Returns are presented gross and net of model fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of model fees. Net returns are calculated by subtracting a model fee of .50% on an annual basis or .04167% on a monthly basis, which includes trading costs and the reinvestment of all income.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. While Large-capitalization companies may have more stable prices than smaller, less established companies, they are still subject to equity securities risk. In addition, large-capitalization equity security prices may not rise as much as prices of equity securities of small-capitalization companies. Securities of small- and medium-sized companies tend to have a shorter history of operations and be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks. The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Capital does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Capital Management, LLC is an independent registered investment adviser under the Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Capital, including our investment strategies, fees and objectives, can be found in our ADV Part 2, which is available upon request. ACM-2610-32

Performance Disclosures

Sources: CAPS CompositeHubTM, Russell Investments, Standard & Poor’s

Past performance is not indicative of future results. The information provided should not be considered financial advice or a recommendation to purchase or sell any particular security or product. Performance results for periods greater than one year have been annualized. The Aristotle Value Equity strategy has an inception date of November 1, 2010; however, the strategy initially began at Mr. Gleicher’s predecessor firm in October 1997. A supplemental performance track record from January 1, 2001 through October 31, 2010 is provided above. The returns are based on two separate accounts and performance results are based on custodian data. During this time, Mr. Gleicher had primary responsibility for managing the two accounts, one account starting in November 2000 and the other in December 2000.

Composite and supplemental returns are presented gross and net of model fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of model fees. Net returns are calculated by subtracting a model fee of 0.50% on an annual basis or 0.04167% on a monthly basis, which includes trading costs and the reinvestment of all income.

Index Disclosures

The Russell 1000® Value Index measures the performance of the large cap value segment of the U.S. equity universe. It includes those Russell 1000 Index companies with lower price-to-book ratios and lower expected growth values. The S&P 500® Index is the Standard & Poor’s Composite Index of 500 stocks and is a widely recognized, unmanaged index of common stock prices.  It is market cap weighted and includes 500 leading companies, capturing approximately 80% coverage of available market capitalization. The S&P 500 Equal Weight Index is designed to be the size-neutral version of the S&P 500. It includes the same constituents as the cap-weighted S&P 500, but each company in the S&P 500 Equal Weight Index is allocated the same weight at each quarterly rebalance. The Russell 1000® Growth Index measures the performance of the large cap growth segment of the U.S. equity universe. It includes those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values. The Russell 2000® Index measures the performance of the small cap segment of the U.S. equity universe. The Russell 2000 Index is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2,000 of the smallest securities based on a combination of their market cap and current index membership. The Dow Jones Industrial Average® is a price-weighted measure of 30 U.S. blue-chip companies. The Index covers all industries except transportation and utilities. The NASDAQ Composite Index measures all NASDAQ domestic and international based common type stocks listed on The NASDAQ Stock Market. The NASDAQ Composite includes over 3,000 companies, more than most other stock market indexes. The Bloomberg U.S. Aggregate Bond Index is an unmanaged index of domestic investment grade bonds, including corporate, government and mortgage-backed securities. The WTI Crude Oil Index is a major trading classification of sweet light crude oil that serves as a major benchmark price for oil consumed in the United States. The 3-Month U.S. Treasury Bill is a short-term debt obligation backed by the U.S. Treasury Department with a maturity of three months. The volatility (beta) of the Composite may be greater or less than its respective benchmarks. It is not possible to invest directly in these indices.

ARISTOTLE CAPITAL BOSTON, LLC

Markets Review

U.S. small/mid cap equities retreated during the third quarter of 2026, underperforming large cap stocks as investor capital rotated back toward mega cap technology and AI beneficiaries following an exceptionally strong first half of 2026. The Russell 2500 Index declined -6.37% during the quarter as rising Treasury yields, higher energy prices, and renewed inflation concerns weighed on risk appetite and compressed valuation multiples across many economically sensitive businesses. Despite the third quarter consolidation, small cap fundamentals remained constructive. Many of the quarter’s laggards had been among the strongest performers earlier in the year, and profit taking combined with a narrow rally in large cap technology masked continued improvement in earnings expectations across much of the small cap universe. As a result, the asset class retained a meaningful year to date advantage over larger cap equities at quarter end, supported by attractive relative valuations and improving operating fundamentals.

Stylistically, value stocks outperformed their growth counterparts during the quarter, with the Russell 2500 Value Index returning -4.36% compared to the -10.35% return of the Russell 2500 Growth Index. Sector performance was highly uneven. Energy was among the strongest contributors as crude oil prices surged during the quarter, benefiting small cap exploration, production, and oilfield services companies. Healthcare was another bright spot, supported by resilient earnings and company specific execution within Life Sciences and Health Care Equipment despite declines in Biotechnology and Pharmaceuticals. Conversely, several of the index’s largest cyclical exposures weighed on returns. Industrials, Consumer Discretionary,  Utilities and Real Estate underperformed as higher interest rates and tighter financial conditions pressured investor sentiment toward domestically focused companies. Rate sensitive industries such as commercial real estate, housing related businesses, and other capital intensive sectors faced additional headwinds from sharply higher long-term bond yields. From a factor perspective, low volatility, value and quality had the strongest payoffs, while beta, high leverage and momentum had negative payoffs.

Almost all sectors paid off negatively during the third quarter. The best performing sectors were Energy (+7.00%), Health Care (+1.78%), and Financials (-4.06%) while conversely the worst performing sectors were Industrials (-14.64%), Consumer Discretionary (-10.46%), and Utilities (-9.23%).

Sources: CAPS Composite Hub, Russell Investments
Past performance is not indicative of future results. Aristotle Small/Mid Cap Equity WM Composite returns are presented gross and net of the maximum wrap fee and include the reinvestment of all income. Net returns are calculated by subtracting the highest applicable wrap/SMA fee, which includes trading costs and custodial fees, from the gross monthly composite return (2.00% on an annual basis, or 0.167% monthly). Please see important disclosures at the end of this document.

Performance Review

For the third quarter of 2026, the Aristotle Small/Mid Cap Equity WM Composite generated a total return of -4.53% net of fees (-4.05% gross of fees), outperforming the -6.37% total return of the Russell 2500 Index. Security selection and allocation effect both contributed to performance. The largest contributors to relative performance were security selection in Health Care (owning Haemonetics coupled with not owning biotechnology stocks)  and Industrials coupled with an underweight allocation to Consumer Discretionary and an overweight allocation to Financials. This was partially offset by security selection in the Consumer Discretionary and Materials sectors coupled with underweight allocations to Health Care and Communication Services.

Relative ContributorsRelative Detractors
Huron Consulting GroupFTAI Aviation
HaemoneticsMACOM Technology Solutions
Charles River LaboratoriesMercury Systems
Merit Medical SystemsDycom Industries
Encompass HealthScotts Miracle-Gro

CONTRIBUTORS

Huron Consulting Group (HURN), is a provider of technology, data, analytics, and consulting solutions to healthcare, education, and commercial clients. The stock contributed positively during the quarter as the company delivered record financial results, exceeded earnings expectations, and raised full year guidance. Strong demand for healthcare, education, and digital transformation services, coupled with consistent double digit revenue growth, margin expansion, and increasing exposure to higher value managed services and AI-enabled solutions, supported investor sentiment. We continue to hold the position, as we believe the company is well positioned to benefit from durable demand, expanding profitability, and long-term secular growth driven by digital transformation and increasing regulatory complexity across its end markets.

Haemonetics (HAE), is a global provider of hematology and blood management products and solutions. The company  delivered better than expected financial results, driven by strong performance in its plasma and hospital businesses, expanding margins, and improving cash flow generation. Investors responded favorably to the company’s disciplined execution, market share gains, and growing confidence in its ability to deliver sustainable earnings growth and shareholder value. We believe that the company’s strong competitive position within the plasmapheresis market along with increased investment in research and development should create value for shareholders over a multi-year period.

DETRACTORS

FTAI Aviation (FTAI), owns and leases aircraft engines and operates a maintenance, repair, and exchange (MRE) platform. FTAI Aviation underperformed during the quarter as weaker than expected earnings, near-term margin pressures, and lingering investor uncertainty prompted a reassessment of its valuation following strong prior appreciation. We continue to hold the position, as we believe growing air travel demand, an aging global engine fleet, and the company’s evolving asset light leasing strategy support attractive long-term earnings growth and shareholder value creation.

MACOM Technology Solutions (MTSI), is a designer and manufacturer of high performance semiconductor products. The stock declined during the quarter as investor sentiment toward AI and semiconductor related stocks weakened following a period of strong share price appreciation. While the company continued to deliver robust operating results, including record revenue, bookings, and backlog, concerns regarding the pace of future AI infrastructure spending and broader valuation pressures weighed on the shares. We maintain our position, as we believe the company’s meaningful exposure to growing demand from Data Center and 5G end market applications along with the integration of recent acquisitions and domestic manufacturing footprint should continue to drive shareholder value.

Recent Portfolio Activity

Buys/AcquisitionsSells/Liquidations
Bentley SystemsEssential Utilities
CorpayEuronet Worldwide
FreshpetGartner
TrimbleKnowles
U.S. Physical TherapyOceaneering International
Weatherford InternationalSLR Investment Corp

BUYS/ACQUISITIONS

Bentley Systems (BSY), is an infrastructure engineering software company that provides software and digital twin solutions used to design, build, and operate critical infrastructure across transportation, water, energy, and construction markets worldwide. We believe the company offers a rare combination of mission critical infrastructure software, highly recurring revenue, and consistent double digit margin expansion coupled with revenue growth, supported by long-term tailwinds from global infrastructure investment, electrification, and grid modernization. We believe the company is attractive due to its strong free cash flow, high customer retention, and durable competitive advantages trading at a discount to our estimates of its long-term intrinsic value. These characteristics should support improving earnings growth and long term shareholder value.

Corpay (CPAY), is a corporate payments and expense management platform that helps businesses automate payables, manage cross-border transactions, and control vehicle related spending. The company offers a combination of double digit organic revenue growth, high customer retention, and strong free cash flow generation. We believe that the company has significant potential for continued market share gains in large, underpenetrated payments markets which may support improving earnings growth and long term shareholder value.

Freshpet (FRPT), is a premium pet food company that manufactures and distributes fresh, refrigerated dog and cat food through a proprietary network of branded refrigerators in retail stores across North America. We believe the company is well positioned to benefit from secular growth in premium pet nutrition, with accelerating market share gains, expanding distribution, and strong brand loyalty, supported by double digit revenue growth, rising margins, increasing free cash flow, and upward earnings guidance, which may suggest the market was underappreciating the company’s long-term earnings growth and shareholder value.

Trimble (TRMB), is a provider of software, data, and positioning solutions that help customers across the construction, agriculture, geospatial, and transportation industries improve productivity and automate workflows. We believe the company is well positioned to benefit from a growing base of recurring revenue, continued margin expansion, and long-term digitalization trends as it evolves from a hardware focused business into a higher margin software and subscription platform, which may support attractive earnings growth and long-term shareholder value creation.

U.S. Physical Therapy (USPH), is an operator of outpatient physical and occupational therapy clinics, providing rehabilitation services and workplace injury prevention solutions through a nationwide network of partner-led practices. We believe the company may benefit from an aging population, increasing demand for outpatient rehabilitation services, and continued market consolidation. We believe its disciplined acquisition strategy, expanding clinic network, and opportunities for operational efficiencies and margin improvement will support sustainable earnings growth and long-term shareholder value creation.

Weatherford International (WFRD), is a global oilfield services and equipment provider that helps energy producers optimize drilling, well construction, production, and asset performance through a combination of engineering expertise, advanced technologies, and digital solutions. The company has what we believe to be strong free cash flow generation, a fortress balance sheet that provides financial flexibility, and disciplined margin management. We believe the company is well positioned to benefit from continued investment in international and offshore oil and gas development, supported by its exposure to longer cycle production and well-optimization activities. We believe its focus on higher margin technologies, operational efficiencies, and disciplined capital allocation will support sustainable earnings growth, margin expansion, and long-term shareholder value creation.

SELLS/LIQUIDATIONS

Essential Utilities (WTRG), is a regulated utility company that provides water, wastewater, and natural gas services to customers across multiple U.S. states through its Aqua and Peoples Natural Gas subsidiaries. We exited the position as the share price appreciated reducing the stock’s potential upside and made its risk/reward profile less compelling redeploying the capital into what we view as higher conviction opportunities.

Euronet Worldwide (EEFT), is a global payments and fintech company that provides ATM outsourcing, electronic payment processing, prepaid solutions, and cross-border money transfer services through brands including Ria and XE. The position was liquidated due to increased uncertainty surrounding the pace of recovery and potential margin pressures that diminished the attractiveness of the risk/reward profile, prompting us to redeploy capital into higher conviction opportunities.

Gartner (IT), is a provider of technology research, advisory, consulting, and conference services that help organizations make strategic business and technology decisions. The position was liquidated due to deteriorating fundamentals.

Knowles (KN), is a specialty electronic components company that designs and manufactures high performance capacitors, RF filters, medical microphones, and advanced audio components for the defense, medtech, industrial, and electrification markets. We exited our position in Knowles following strong share price appreciation, which reduced the potential upside and made the risk/reward profile less compelling. We subsequently redeployed capital into investment opportunities offering what we consider to be more attractive valuations and greater long-term return potential.

Oceaneering International (OII), is a global technology and engineering company that provides subsea robotics, offshore services, and mission critical solutions to the energy, defense, aerospace, and industrial markets. We exited the position after Q2 earnings beat expectations resulting in the stock’s appreciation which compressed the risk/reward profile. We took profits on this position, and the proceeds were redeployed into what we consider to be higher conviction opportunities.

SLR Investment Corp (SLRC), is a business development company that provides senior secured loans and specialty finance solutions to U.S. middle market companies, generating income for shareholders through a diversified private credit portfolio. The position was liquidated due to deteriorating fundamentals.

Outlook

We remain constructive on the long-term outlook for the small/mid-cap segment of the U.S. market. Valuations continue to appear attractive, with the Russell 2500 Index trading near multi-decade lows relative to large caps, while earnings continue to accelerate. Consensus estimates point to small cap earnings growth surpassing large cap growth by late 2026/early 2027. A strong US GDP environment, incremental increases in M&A activity, improving domestic manufacturing trends supported by reshoring and infrastructure investment, and a more favorable regulatory and tariff backdrop should provide longer term tailwinds for the asset class. Near term, we remain cautious as geopolitical risks, including the Iran conflict and related inflationary spillovers, may contribute to elevated volatility. Separately, mid-term election uncertainty has historically been associated with increased market volatility but has often given way to more durable small cap recoveries following the election cycle.

Positioning

Our current positioning is a function of our bottom-up security selection process and our ability to identify what we view as attractive investment candidates, regardless of economic sector definitions. Overweights in Information Technology and Financials are mostly a function of our underlying company specific views rather than any top-down predictions for each sector. Conversely, we continue to be underweight in Consumer Discretionary, as we have been unable to identify what we consider to be compelling long-term opportunities that fit our discipline given the rising risk profiles of many retail businesses and a potential deceleration in goods spending following a period of strength. We are also underweight in Real Estate, as the sector has elevated interest rate sensitivity, refinancing risk, and structural challenges in segments such as office and retail, combined with generally weaker balance sheets, leading us to seek what we consider to be more attractive reward to risk opportunities. Given our focus on long-term business fundamentals, our patient investment approach and low portfolio turnover, the strategy’s sector positioning generally does not change significantly from quarter to quarter. However, we may take advantage of periods of volatility by adding selectively to certain companies when appropriate.

Disclosures

The opinions expressed herein are those of Aristotle Capital Boston, LLC (Aristotle Boston) and are subject to change without notice.

Past performance is not indicative of future results. The information provided in this report should not be considered financial advice or a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Boston’s Small/Mid Cap Equity WM Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. It should not be assumed that any of the securities transactions, holdings or sectors discussed were or will be profitable, or that the investment recommendations or decisions Aristotle Boston makes in the future will be profitable or equal the performance of the securities discussed herein. Aristotle Boston reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. Recommendations made in the last 12 months are available upon request.

Composite returns are presented gross and net of the maximum wrap fee and include the reinvestment of all income. Net returns are calculated by subtracting the highest applicable wrap/SMA fee, which includes trading costs and custodial fees, from the gross monthly composite return (2.00% on an annual basis, or 0.167% monthly).

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. While Large-capitalization companies may have more stable prices than smaller, less established companies, they are still subject to equity securities risk. In addition, large-capitalization equity security prices may not rise as much as prices of equity securities of small-capitalization companies. Securities of small- and medium-sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks. The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Boston does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Capital Boston, LLC is an independent investment adviser registered under the Investment Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Boston, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. ACB-2610-3

Performance Disclosures

Sources: CAPS Composite Hub, Russell Investments

*The Aristotle Small/Mid Cap Equity WM Composite (“Composite”) has an inception date of January 1, 2008, at a predecessor firm. During this time, Jack McPherson and Dave Adams had primary responsibility for managing the strategy. Performance starting January 1, 2015, was achieved at Aristotle Boston.

The Composite includes all discretionary accounts managed in this strategy and is based on the institutional composite track record. The composite currently consists of only institutional accounts and does not contain any fully bundled fee wrap portfolios. Past performance is not indicative of future results. Performance results for periods greater than one year have been annualized. Composite returns are presented gross and net of the maximum wrap fee and include the reinvestment of all income. Net returns are calculated by subtracting the highest applicable wrap/SMA fee, which includes trading costs and custodial fees, from the gross monthly composite return (2.00% on an annual basis, or 0.167% monthly). Please see important disclosures enclosed within
this document.

Index Disclosures

The Russell 2500® Index measures the performance of the small to mid cap segment of the U.S. equity universe. The Russell 2500 Index is a subset of the Russell 3000® Index. It includes approximately 2500 of the smallest securities based on a combination of their market cap and current index membership. The Russell 2500 Growth® Index measures the performance of the small/mid cap companies located in the United States that also exhibit a growth probability. The Russell 2500 Value® Index measures the performance of the small/mid cap companies located in the United States that also exhibit a value probability. The volatility (beta) of the composite may be greater or less than the benchmarks. It is not possible to invest directly in these indices.

For more on Small Cap Equity, access the latest resources.

ARISTOTLE CAPITAL BOSTON, LLC

Markets Review

U.S. small/mid cap equities retreated during the third quarter of 2026, underperforming large cap stocks as investor capital rotated back toward mega cap technology and AI beneficiaries following an exceptionally strong first half of 2026. The Russell 2500 Index declined -6.37% during the quarter as rising Treasury yields, higher energy prices, and renewed inflation concerns weighed on risk appetite and compressed valuation multiples across many economically sensitive businesses. Despite the third quarter consolidation, small cap fundamentals remained constructive. Many of the quarter’s laggards had been among the strongest performers earlier in the year, and profit taking combined with a narrow rally in large cap technology masked continued improvement in earnings expectations across much of the small cap universe. As a result, the asset class retained a meaningful year to date advantage over larger cap equities at quarter end, supported by attractive relative valuations and improving operating fundamentals.

Stylistically, value stocks outperformed their growth counterparts during the quarter, with the Russell 2500 Value Index returning -4.36% compared to the -10.35% return of the Russell 2500 Growth Index. Sector performance was highly uneven. Energy was among the strongest contributors as crude oil prices surged during the quarter, benefiting small cap exploration, production, and oilfield services companies. Healthcare was another bright spot, supported by resilient earnings and company specific execution within Life Sciences and Health Care Equipment despite declines in Biotechnology and Pharmaceuticals. Conversely, several of the index’s largest cyclical exposures weighed on returns. Industrials, Consumer Discretionary,  Utilities and Real Estate underperformed as higher interest rates and tighter financial conditions pressured investor sentiment toward domestically focused companies. Rate sensitive industries such as commercial real estate, housing related businesses, and other capital intensive sectors faced additional headwinds from sharply higher long-term bond yields. From a factor perspective, low volatility, value and quality had the strongest payoffs, while beta, high leverage and momentum had negative payoffs.

Almost all sectors paid off negatively during the third quarter. The best performing sectors were Energy (+7.00%), Health Care (+1.78%), and Financials (-4.06%) while conversely the worst performing sectors were Industrials (-14.64%), Consumer Discretionary (-10.46%), and Utilities (-9.23%).

Sources: CAPS Composite Hub, Russell Investments
Past performance is not indicative of future results. Aristotle Small/Mid Cap Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Please see important disclosures at the end of this document.

Performance Review

For the third quarter of 2026, the Aristotle Small/Mid Cap Equity Composite generated a total return of -4.17% net of fees (-4.05% gross of fees), outperforming the -6.37% total return of the Russell 2500 Index. Security selection and allocation effect both contributed to performance. The largest contributors to relative performance were security selection in Health Care and Industrials coupled with an underweight allocation to Consumer Discretionary and an overweight allocation to Financials. This was partially offset by security selection in the Consumer Discretionary and Materials sectors coupled with underweight allocations to Health Care and Communication Services.

Relative ContributorsRelative Detractors
Huron Consulting GroupFTAI Aviation
HaemoneticsMACOM Technology Solutions
Charles River LaboratoriesMercury Systems
Merit Medical SystemsDycom Industries
Encompass HealthScotts Miracle-Gro

CONTRIBUTORS

Huron Consulting Group (HURN), is a provider of technology, data, analytics, and consulting solutions to healthcare, education, and commercial clients. The stock contributed positively during the quarter as the company delivered record financial results, exceeded earnings expectations, and raised full year guidance. Strong demand for healthcare, education, and digital transformation services, coupled with consistent double digit revenue growth, margin expansion, and increasing exposure to higher value managed services and AI-enabled solutions, supported investor sentiment. We continue to hold the position, as we believe the company is well positioned to benefit from durable demand, expanding profitability, and long-term secular growth driven by digital transformation and increasing regulatory complexity across its end markets.

Haemonetics (HAE), is a global provider of hematology and blood management products and solutions. The company  delivered better than expected financial results, driven by strong performance in its plasma and hospital businesses, expanding margins, and improving cash flow generation. Investors responded favorably to the company’s disciplined execution, market share gains, and growing confidence in its ability to deliver sustainable earnings growth and shareholder value. We believe that the company’s strong competitive position within the plasmapheresis market along with increased investment in research and development should create value for shareholders over a multi-year period.

DETRACTORS

FTAI Aviation (FTAI), owns and leases aircraft engines and operates a maintenance, repair, and exchange (MRE) platform. FTAI Aviation underperformed during the quarter as weaker than expected earnings, near-term margin pressures, and lingering investor uncertainty prompted a reassessment of its valuation following strong prior appreciation. We continue to hold the position, as we believe growing air travel demand, an aging global engine fleet, and the company’s evolving asset light leasing strategy support attractive long-term earnings growth and shareholder value creation.

MACOM Technology Solutions (MTSI), is a designer and manufacturer of high performance semiconductor products. The stock declined during the quarter as investor sentiment toward AI and semiconductor related stocks weakened following a period of strong share price appreciation. While the company continued to deliver robust operating results, including record revenue, bookings, and backlog, concerns regarding the pace of future AI infrastructure spending and broader valuation pressures weighed on the shares. We maintain our position, as we believe the company’s meaningful exposure to growing demand from Data Center and 5G end market applications along with the integration of recent acquisitions and domestic manufacturing footprint should continue to drive shareholder value.

Recent Portfolio Activity

Buys/AcquisitionsSells/Liquidations
Bentley SystemsEssential Utilities
CorpayEuronet Worldwide
FreshpetGartner
TrimbleKnowles
U.S. Physical TherapyOceaneering International
Weatherford InternationalSLR Investment Corp

BUYS/ACQUISITIONS

Bentley Systems (BSY), is an infrastructure engineering software company that provides software and digital twin solutions used to design, build, and operate critical infrastructure across transportation, water, energy, and construction markets worldwide. We believe the company offers a rare combination of mission critical infrastructure software, highly recurring revenue, and consistent double digit margin expansion coupled with revenue growth, supported by long-term tailwinds from global infrastructure investment, electrification, and grid modernization. We believe the company is attractive due to its strong free cash flow, high customer retention, and durable competitive advantages trading at a discount to our estimates of its long-term intrinsic value. These characteristics should support improving earnings growth and long term shareholder value.

Corpay (CPAY), is a corporate payments and expense management platform that helps businesses automate payables, manage cross-border transactions, and control vehicle related spending. The company offers a combination of double digit organic revenue growth, high customer retention, and strong free cash flow generation. We believe that the company has significant potential for continued market share gains in large, underpenetrated payments markets which may support improving earnings growth and long term shareholder value.

Freshpet (FRPT), is a premium pet food company that manufactures and distributes fresh, refrigerated dog and cat food through a proprietary network of branded refrigerators in retail stores across North America. We believe the company is well positioned to benefit from secular growth in premium pet nutrition, with accelerating market share gains, expanding distribution, and strong brand loyalty, supported by double digit revenue growth, rising margins, increasing free cash flow, and upward earnings guidance, which may suggest the market was underappreciating the company’s long-term earnings growth and shareholder value.

Trimble (TRMB), is a provider of software, data, and positioning solutions that help customers across the construction, agriculture, geospatial, and transportation industries improve productivity and automate workflows. We believe the company is well positioned to benefit from a growing base of recurring revenue, continued margin expansion, and long-term digitalization trends as it evolves from a hardware focused business into a higher margin software and subscription platform, which may support attractive earnings growth and long-term shareholder value creation.

U.S. Physical Therapy (USPH), is an operator of outpatient physical and occupational therapy clinics, providing rehabilitation services and workplace injury prevention solutions through a nationwide network of partner-led practices. We believe the company may benefit from an aging population, increasing demand for outpatient rehabilitation services, and continued market consolidation. We believe its disciplined acquisition strategy, expanding clinic network, and opportunities for operational efficiencies and margin improvement will support sustainable earnings growth and long-term shareholder value creation.

Weatherford International (WFRD), is a global oilfield services and equipment provider that helps energy producers optimize drilling, well construction, production, and asset performance through a combination of engineering expertise, advanced technologies, and digital solutions. The company has what we believe to be strong free cash flow generation, a fortress balance sheet that provides financial flexibility, and disciplined margin management. We believe the company is well positioned to benefit from continued investment in international and offshore oil and gas development, supported by its exposure to longer cycle production and well-optimization activities. We believe its focus on higher margin technologies, operational efficiencies, and disciplined capital allocation will support sustainable earnings growth, margin expansion, and long-term shareholder value creation.

SELLS/LIQUIDATIONS

Essential Utilities (WTRG), is a regulated utility company that provides water, wastewater, and natural gas services to customers across multiple U.S. states through its Aqua and Peoples Natural Gas subsidiaries. We exited the position as the share price appreciated reducing the stock’s potential upside and made its risk/reward profile less compelling redeploying the capital into what we view as higher conviction opportunities.  

Euronet Worldwide (EEFT), is a global payments and fintech company that provides ATM outsourcing, electronic payment processing, prepaid solutions, and cross-border money transfer services through brands including Ria and XE. The position was liquidated due to increased uncertainty surrounding the pace of recovery and potential margin pressures that diminished the attractiveness of the risk/reward profile, prompting us to redeploy capital into higher conviction opportunities.

Gartner (IT), is a provider of technology research, advisory, consulting, and conference services that help organizations make strategic business and technology decisions. The position was liquidated due to deteriorating fundamentals.

Knowles (KN), is a specialty electronic components company that designs and manufactures high performance capacitors, RF filters, medical microphones, and advanced audio components for the defense, medtech, industrial, and electrification markets. We exited our position in Knowles following strong share price appreciation, which reduced the potential upside and made the risk/reward profile less compelling. We subsequently redeployed capital into investment opportunities offering what we consider to be more attractive valuations and greater long-term return potential.

Oceaneering International (OII), is a global technology and engineering company that provides subsea robotics, offshore services, and mission critical solutions to the energy, defense, aerospace, and industrial markets. We exited the position after Q2 earnings beat expectations resulting in the stock’s appreciation which compressed the risk/reward profile. We took profits on this position, and the proceeds were redeployed into what we consider to be higher conviction opportunities.

SLR Investment Corp (SLRC), is a business development company that provides senior secured loans and specialty finance solutions to U.S. middle market companies, generating income for shareholders through a diversified private credit portfolio. The position was liquidated due to deteriorating fundamentals.   

Outlook

We remain constructive on the long-term outlook for the small/mid-cap segment of the U.S. market. Valuations continue to appear attractive, with the Russell 2500 Index trading near multi-decade lows relative to large caps, while earnings continue to accelerate. Consensus estimates point to small cap earnings growth surpassing large cap growth by late 2026/early 2027. A strong US GDP environment, incremental increases in M&A activity, improving domestic manufacturing trends supported by reshoring and infrastructure investment, and a more favorable regulatory and tariff backdrop should provide longer term tailwinds for the asset class. Near term, we remain cautious as geopolitical risks, including the Iran conflict and related inflationary spillovers, may contribute to elevated volatility. Separately, mid-term election uncertainty has historically been associated with increased market volatility but has often given way to more durable small cap recoveries following the election cycle.

Positioning

Our current positioning is a function of our bottom-up security selection process and our ability to identify what we view as attractive investment candidates, regardless of economic sector definitions. Overweights in Information Technology and Financials are mostly a function of our underlying company specific views rather than any top-down predictions for each sector. Conversely, we continue to be underweight in Consumer Discretionary, as we have been unable to identify what we consider to be compelling long-term opportunities that fit our discipline given the rising risk profiles of many retail businesses and a potential deceleration in goods spending following a period of strength. We are also underweight in Real Estate, as the sector has elevated interest rate sensitivity, refinancing risk, and structural challenges in segments such as office and retail, combined with generally weaker balance sheets, leading us to seek what we consider to be more attractive reward to risk opportunities. Given our focus on long-term business fundamentals, our patient investment approach and low portfolio turnover, the strategy’s sector positioning generally does not change significantly from quarter to quarter. However, we may take advantage of periods of volatility by adding selectively to certain companies when appropriate.

Disclosures

The opinions expressed herein are those of Aristotle Capital Boston, LLC (Aristotle Boston) and are subject to change without notice.

Past performance is not indicative of future results. The information provided in this report should not be considered financial advice or a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Boston’s Small/Mid Cap Equity Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. It should not be assumed that any of the securities transactions, holdings or sectors discussed were or will be profitable, or that the investment recommendations or decisions Aristotle Boston makes in the future will be profitable or equal the performance of the securities discussed herein. Aristotle Boston reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. Recommendations made in the last 12 months are available upon request.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

As of December 31, 2014, there were no non-fee-paying accounts in the Composite.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. While Large-capitalization companies may have more stable prices than smaller, less established companies, they are still subject to equity securities risk. In addition, large-capitalization equity security prices may not rise as much as prices of equity securities of small-capitalization companies. Securities of small- and medium-sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks. The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Boston does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Capital Boston, LLC is an independent investment adviser registered under the Investment Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Boston, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. ACB-2610 -2

Performance Disclosures

 

Sources: CAPS Composite Hub, Russell Investments

*The Aristotle Small/Mid Cap Equity Composite has an inception date of January 1, 2008, at a predecessor firm. During this time, Jack McPherson and Dave Adams had primary responsibility for managing the strategy. Performance starting January 1, 2015, was achieved at Aristotle Boston.

As of December 31, 2014, there were no non-fee-paying accounts in the Composite. Past performance is not indicative of future results. Performance results for periods greater than one year have been annualized.

Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Please see important disclosures enclosed within this document.

Index Disclosures

The Russell 2500® Index measures the performance of the small to mid cap segment of the U.S. equity universe. The Russell 2500 Index is a subset of the Russell 3000® Index. It includes approximately 2500 of the smallest securities based on a combination of their market cap and current index membership. The Russell 2500 Growth® Index measures the performance of the small/mid cap companies located in the United States that also exhibit a growth probability. The Russell 2500 Value® Index measures the performance of the small/mid cap companies located in the United States that also exhibit a value probability. The volatility (beta) of the composite may be greater or less than the benchmarks. It is not possible to invest directly in these indices.

For more on Small Cap Equity, access the latest resources.

ARISTOTLE CAPITAL BOSTON, LLC

Markets Review

U.S. small cap equities retreated during the third quarter of 2026, underperforming large cap stocks as investor capital rotated back toward mega cap technology and AI beneficiaries following an exceptionally strong first half of 2026. The Russell 2000 Index declined -7.23% during the quarter as rising Treasury yields, higher energy prices, and renewed inflation concerns weighed on risk appetite and compressed valuation multiples across many economically sensitive businesses. Despite the third quarter consolidation, small cap fundamentals remained constructive. Many of the quarter’s laggards had been among the strongest performers earlier in the year, and profit taking combined with a narrow rally in large cap technology masked continued improvement in earnings expectations across much of the small cap universe. As a result, the asset class retained a meaningful year to date advantage over larger cap equities at quarter end, supported by attractive relative valuations and improving operating fundamentals.

Stylistically, value stocks outperformed their growth counterparts during the quarter, with the Russell 2000 Value Index returning -4.91% versus -9.39% for the Russell 2000 Growth Index. Sector performance was highly uneven. Energy was among the strongest contributors as crude oil prices surged during the quarter, benefiting small cap exploration, production, and oilfield services companies. Industries within technology also provided areas of strength, particularly within software and select semiconductor related businesses, as investor enthusiasm surrounding artificial intelligence reaccelerated and concerns about AI driven disruption to traditional software models eased. Healthcare was another relative bright spot, supported by resilient earnings and company specific execution. Conversely, several of the index’s largest cyclical exposures weighed on returns. Industrials, Real Estate, and portions of Consumer Discretionary underperformed as higher interest rates and tighter financial conditions pressured investor sentiment toward domestically focused companies. Rate sensitive industries such as commercial real estate, housing related businesses, and other capital intensive sectors faced additional headwinds from sharply higher long-term bond yields. From a factor perspective, low volatility, value and quality had the strongest payoffs, while beta, high leverage and momentum had negative payoffs.

Almost all sectors paid off negatively during the third quarter. The best performing sectors were Energy (+6.36%), Health Care (­-1.42%), and Financials (-5.19%) while conversely the worst performing sectors were Industrials (-14.54%), Information Technology (-12.07%), and Consumer Discretionary (-10.48%).

 

Sources: CAPS Composite Hub, Russell Investments
Past performance is not indicative of future results. Aristotle Small Cap Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Please see important disclosures at the end of this document.

Performance Review

For the third quarter of 2026, the Aristotle Small Cap Equity Composite posted a total return of -3.93% net of fees (-3.76% gross of fees), outperforming the -7.23% total return of the Russell 2000 Index. Security selection contributed to performance, while allocation effect detracted from results. The largest contributors on a relative basis were security selection in the Health Care and Information Technology sectors coupled with underweight allocations to Consumer Discretionary and Real Estate. This was partially offset by security selection in the Consumer Discretionary and Materials sectors paired with an underweight position in Health Care and an overweight position in Information Technology.

Relative ContributorsRelative Detractors
Huron Consulting GroupMercury Systems
HaemoneticsMACOM Technology Solutions
Ardmore ShippingDycom Industries
Charles River LaboratoriesWillScot Holdings
Merit Medical SystemsScotts Miracle-Gro Company

CONTRIBUTORS

Huron Consulting Group (HURN), is a provider of technology, data, analytics, and consulting solutions to healthcare, education, and commercial clients. The stock contributed positively during the quarter as the company delivered record financial results, exceeded earnings expectations, and raised full year guidance. Strong demand for healthcare, education, and digital transformation services, coupled with consistent double digit revenue growth, margin expansion, and increasing exposure to higher value managed services and AI-enabled solutions, supported investor sentiment. We continue to hold the position, as we believe the company is well positioned to benefit from durable demand, expanding profitability, and long-term secular growth driven by digital transformation and increasing regulatory complexity across its end markets.

Haemonetics (HAE), is a global provider of hematology and blood management products and solutions. The company  delivered better than expected financial results, driven by strong performance in its plasma and hospital businesses, expanding margins, and improving cash flow generation. Investors responded favorably to the company’s disciplined execution, market share gains, and growing confidence in its ability to deliver sustainable earnings growth and shareholder value. We believe that the company’s strong competitive position within the plasmapheresis market along with increased investment in research and development should create value for shareholders over a multi-year period.

DETRACTORS

Mercury Systems (MRCY), is a developer of mission critical computing, signal processing, software, and secure electronics technologies used in aerospace and defense applications. The stock declined over the quarter as higher operating expenses, weaker free cash flow, and below-target fiscal 2027 cash flow guidance overshadowed record revenue and bookings. Despite strong demand and a growing backlog, investor concerns regarding the pace of margin recovery and cash flow improvement weighed on the stock. We maintain our position as we believe Mercury Systems is emerging from a multi-year operational reset, with improving execution, expanding margins, and lower leverage. In addition, we believe the stock is trading at attractive valuations relative to its normalized earnings power given the strong underlying demand across its aerospace and defense end markets, which should continue to create shareholder value over time.

MACOM Technology Solutions (MTSI), is a designer and manufacturer of high performance semiconductor products. The stock declined during the quarter as investor sentiment toward AI and semiconductor related stocks weakened following a period of strong share price appreciation. While the company continued to deliver robust operating results, including record revenue, bookings, and backlog, concerns regarding the pace of future AI infrastructure spending and broader valuation pressures weighed on the shares. We maintain our position, as we believe the company’s meaningful exposure to growing demand from Data Center and 5G end market applications along with the integration of recent acquisitions and domestic manufacturing footprint should continue to drive shareholder value.

Recent Portfolio Activity

Buys/AcquisitionsSells/Liquidations
Bentley SystemsCross Country Healthcare
FreshpetEuronet Worldwide
U.S. Physical TherapyKnowles
Weatherford InternationalOceaneering International
SLR Investment Corp

BUYS/ACQUISITIONS

Bentley Systems (BSY), is an infrastructure engineering software company that provides software and digital twin solutions used to design, build, and operate critical infrastructure across transportation, water, energy, and construction markets worldwide. We believe the company offers a rare combination of mission critical infrastructure software, highly recurring revenue, and consistent double digit margin expansion coupled with revenue growth, supported by long-term tailwinds from global infrastructure investment, electrification, and grid modernization. We believe the company is attractive due to its strong free cash flow, high customer retention, and durable competitive advantages trading at a discount to our estimates of its long-term intrinsic value. These characteristics should support improving earnings growth and long term shareholder value.

Freshpet (FRPT), is a premium pet food company that manufactures and distributes fresh, refrigerated dog and cat food through a proprietary network of branded refrigerators in retail stores across North America. We believe the company is well positioned to benefit from secular growth in premium pet nutrition, with accelerating market share gains, expanding distribution, and strong brand loyalty, supported by double digit revenue growth, rising margins, increasing free cash flow, and upward earnings guidance, which may suggest the market was underappreciating the company’s long-term earnings growth and shareholder value.

U.S. Physical Therapy (USPH), is an operator of outpatient physical and occupational therapy clinics, providing rehabilitation services and workplace injury prevention solutions through a nationwide network of partner-led practices. We believe the company may benefit from an aging population, increasing demand for outpatient rehabilitation services, and continued market consolidation. We believe its disciplined acquisition strategy, expanding clinic network, and opportunities for operational efficiencies and margin improvement will support sustainable earnings growth and long-term shareholder value creation.

Weatherford International (WFRD), is a global oilfield services and equipment provider that helps energy producers optimize drilling, well construction, production, and asset performance through a combination of engineering expertise, advanced technologies, and digital solutions. The company has what we believe to be strong free cash flow generation, a fortress balance sheet that provides financial flexibility, and disciplined margin management. We believe the company is well positioned to benefit from continued investment in international and offshore oil and gas development, supported by its exposure to longer cycle production and well-optimization activities. We believe its focus on higher margin technologies, operational efficiencies, and disciplined capital allocation will support sustainable earnings growth, margin expansion, and long-term shareholder value creation.

SELLS/LIQUIDATIONS

Cross Country Healthcare (CCRN), is a healthcare workforce solutions company that provides staffing, recruitment, and talent management services for hospitals, health systems, physician groups, and other healthcare providers across the U.S. The company was acquired by All Star Recruiting Locums, a portfolio company of Knox Lane LP, and taken private.

Euronet Worldwide (EEFT), is a global payments and fintech company that provides ATM outsourcing, electronic payment processing, prepaid solutions, and cross-border money transfer services through brands including Ria and XE. The position was liquidated due to increased uncertainty surrounding the pace of recovery and potential margin pressures that diminished the attractiveness of the risk/reward profile, prompting us to redeploy capital into higher conviction opportunities.

Knowles (KN), is a specialty electronic components company that designs and manufactures high performance capacitors, RF filters, medical microphones, and advanced audio components for the defense, medtech, industrial, and electrification markets. We exited our position in Knowles following strong share price appreciation, which reduced the potential upside and made the risk/reward profile less compelling. We subsequently redeployed capital into investment opportunities offering what we consider to be more attractive valuations and greater long-term return potential.

Oceaneering International (OII), is a global technology and engineering company that provides subsea robotics, offshore services, and mission critical solutions to the energy, defense, aerospace, and industrial markets. We exited the position after Q2 earnings beat expectations resulting in the stock’s appreciation which compressed the risk/reward profile. We took profits on this position, and the proceeds were redeployed into what we consider to be  higher conviction opportunities.

SLR Investment Corp (SLRC), is a business development company that provides senior secured loans and specialty finance solutions to U.S. middle market companies, generating income for shareholders through a diversified private credit portfolio. The position was liquidated due to deteriorating fundamentals.

Outlook

We remain constructive on the long term outlook for U.S. small cap equities. Valuations continue to appear attractive, with the Russell 2000 trading near multi-decade lows relative to large caps, while earnings continue to accelerate. Consensus estimates point to small cap earnings growth surpassing large cap growth by late 2026/early 2027. A strong US GDP environment, incremental increases in M&A activity, improving domestic manufacturing trends supported by reshoring and infrastructure investment, and a more favorable regulatory and tariff backdrop should provide longer term tailwinds for the asset class. Near term, we remain cautious as geopolitical risks, including the Iran conflict and related inflationary spillovers, may contribute to elevated volatility. Separately, mid-term election uncertainty has historically been associated with increased market volatility but has often given way to more durable small cap recoveries following the election cycle.

Positioning

Our current positioning is a function of our bottom-up security selection process and our ability to identify what we view as attractive investment candidates, regardless of economic sector definitions. Overweight allocations in Information Technology and Industrials are mostly a function of our underlying company specific views rather than any top-down predictions for each sector. Conversely, we continue to be underweight in Health Care as we do not hold Biotechnology companies as that industry has significant binary risk. We are also underweight in Real Estate, as the sector has elevated interest rate sensitivity, refinancing risk, and structural challenges in segments such as office and retail, combined with generally weaker balance sheets, leading us to seek what we consider to be more attractive reward to risk opportunities. Given our focus on long term business fundamentals, our patient investment approach and low portfolio turnover, the strategy’s positioning generally does not change significantly from quarter to quarter. However, we may take advantage of periods of volatility by adding selectively to certain companies when appropriate.

Disclosures

The opinions expressed herein are those of Aristotle Capital Boston, LLC (Aristotle Boston) and are subject to change without notice.

Past performance is not indicative of future results. The information provided in this report should not be considered financial advice or a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Boston’s Small Cap Equity Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. It should not be assumed that any of the securities transactions, holdings or sectors discussed were or will be profitable, or that the investment recommendations or decisions Aristotle Boston makes in the future will be profitable or equal the performance of the securities discussed herein. Aristotle Boston reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. Recommendations made in the last 12 months are available upon request.

Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

Effective January 1, 2022, the Aristotle Small Cap Equity Composite has been redefined to exclude accounts with meaningful industry-specific restrictions or substantial values-based screens hampering implementation of the small cap strategy.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. While Large-capitalization companies may have more stable prices than smaller, less established companies, they are still subject to equity securities risk. In addition, large-capitalization equity security prices may not rise as much as prices of equity securities of small-capitalization companies. Securities of small- and medium-sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks. The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Boston does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Capital Boston, LLC is an independent investment adviser registered under the Investment Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Boston, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. ACB-2610-1

Performance Disclosures

Sources: CAPS Composite Hub, Russell Investments

*The Aristotle Small Cap Equity Composite has an inception date of November 1, 2006, at a predecessor firm. During this time, Jack McPherson and Dave Adams had primary responsibility for managing the strategy. Performance starting January 1, 2015, was achieved at Aristotle Boston.

**For the period November 2006 through December 2006.

Past performance is not indicative of future results. Performance results for periods greater than one year have been annualized.

Effective January 1, 2022, the Aristotle Small Cap Equity Composite has been redefined to exclude accounts with meaningful industry-specific restrictions or substantial values-based screens hampering implementation of the small cap strategy.

Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Please see important disclosures enclosed within this document.

Index Disclosures

The Russell 2000® Index measures the performance of the small cap segment of the U.S. equity universe. The Russell 2000 Index is a subset of the Russell 3000® Index. It includes approximately 2,000 of the smallest securities based on a combination of their market capitalization and current index membership. The Russell 2000 Growth® Index measures the performance of the small cap companies located in the United States that also exhibit a growth probability. The Russell 2000 Value® Index measures the performance of the small cap companies located in the United States that also exhibit a value probability. The volatility (beta) of the composite may be greater or less than the benchmarks. It is not possible to invest directly in these indices.

For more on Small Cap Equity, access the latest resources.

Markets Review

The U.S. equity market advanced during the third quarter of 2026, with the S&P 500 Index rising 2.30% despite heightened geopolitical uncertainty and rising interest rates. In contrast, fixed income markets weakened as rising Treasury yields pressured prices, with the Bloomberg U.S. Aggregate Bond Index declining 3.51%.

On a sector basis, six of the eleven sectors within the Russell 1000 Growth Index posted gains in the third quarter of 2026. The strongest-performing sectors were Energy and Information Technology, supported by higher energy prices and continued AI-related investment, respectively. The weakest sectors were Utilities and Industrials.

Market leadership remained concentrated in a relatively narrow group of companies, with gains in the S&P 500 Index driven by continued enthusiasm surrounding artificial intelligence and related capital investment. Leadership shifted within technology, as software stocks recovered from earlier weakness while semiconductors pulled back following the second quarter rally.

Sources: CAPS CompositeHubTM, Bloomberg
Past performance is not indicative of future results. Aristotle Atlantic Large Cap Growth Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Please see important disclosures at the end of this document.

Geopolitical uncertainty remained elevated as U.S.-Iran negotiations stalled and renewed hostilities disrupted energy supplies and shipping in the Middle East. Oil and refined-product prices rose sharply, with diesel markets particularly constrained. Disruptions to Russian refining capacity added to supply pressures as the conflict in Ukraine remained volatile, reinforcing concerns surrounding global energy availability and inflation.

Inflation remained elevated, with the CPI rising 3.4% year-over-year in August as gasoline prices accounted for more than one-third of the monthly increase. Against the backdrop of resilient consumer spending and economic growth, the Federal Reserve raised its federal funds target range by 0.25 percentage points to 3.75%-4.00% in September, marking a stark reversal from expectations for multiple rate cuts at the beginning of the year.

Performance and Attribution Summary

For the third quarter of 2026, Aristotle Atlantic’s Large Cap Growth Composite posted a total return of 3.73% gross of fees (3.62% net of fees), outperforming the 0.92% return of the Russell 1000 Growth Index.

Performance (%) QTDYTD1 Year3 Years5 YearsSince Inception*
Large Cap Growth Composite (gross)3.7313.7815.0325.5212.1018.10
Large Cap Growth Composite (net)3.6213.3614.4524.8711.5717.59
Russell 1000 Growth Index0.926.307.5024.2613.6618.61
*The Large Cap Growth Composite has an inception date of November 1, 2016. Past performance is not indicative of future results. Aristotle Atlantic Large Cap Growth Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Please see important disclosures at the end of this document.

Sources: FactSet
Past performance is not indicative of future results. Sector attribution shows how much of a portfolio’s overall return is directly attributable to stock selection and asset allocation decisions within the portfolio, highlighting which sectors contributed or detracted to the total return. Attribution includes the reinvestment of income. Attribution is presented gross of fees and does not include the deduction of all fees and expenses that a client or investor has paid or would have paid. Please refer to the gross and net composite returns included within to understand the overall impact of fees. Please see important disclosures at the end of this document.

During the third quarter, the portfolio’s outperformance relative to the Russell 1000 Growth Index was due to security selection, while allocation effects detracted. Security selection in Health Care and Consumer Discretionary contributed the most to relative performance. Conversely, security selection in Information Technology and an overweight in Consumer Discretionary detracted from relative performance.

Contributors and Detractors for 3Q 2026

Relative ContributorsRelative Detractors
Adaptive BiotechnologiesKLA Corporation
CrowdStrike HoldingsWestern Digital
Guardant HealthSanDisk
TeslaCoherent
SnowflakeQuanta Services

Relative contributors and detractors are based on attribution total effect and exclude benchmark securities not held in the portfolio.

Contributors

Adaptive Biotechnologies

Adaptive Biotechnologies contributed to performance in the quarter following second quarter earnings where the company beat consensus estimates and raised full-year revenue guidance on the back of strong clonoSEQ volume and rising average selling prices. Investor sentiment rose following Adaptive’s announcement of plans to separate its Immune Medicine business; this will result in a standalone Minimal Residual Disease diagnostic company.

CrowdStrike Holdings

CrowdStrike contributed to performance in the third quarter after fiscal second quarter 2027 results beat across the board, with record net new ARR and a raised full-year outlook. The post-Mythos environment is driving customers toward consolidated security spend as AI expands the threat surface, and the company is capturing it. As attackers use AI to find and exploit vulnerabilities faster, security is becoming a less discretionary line item in IT budgets, and the threat surface now extends well beyond the endpoint to cloud workloads, identities and AI agents themselves. We believe that newer categories give CrowdStrike a longer growth runway than its core business alone, and the company is moving into them from a position of incumbency. We continue to view the company as the platform of record for AI-era cybersecurity.

Detractors

KLA Corporation

KLA detracted from performance in the third quarter despite record fiscal fourth quarter results and a guide for roughly 9% sequential revenue growth. Shares sold off after the late-July print as investors focused on a flat gross margin guide despite higher revenue, a lingering memory pricing headwind and a beat that was modest relative to elevated expectations. The selling broadened in August as scrutiny of AI infrastructure financing drove a repricing across the wafer fab equipment group. The stock recovered some ground in September but ended the quarter below pre-earnings levels. The company remains structurally leveraged to the AI buildout, as greater silicon intensity across accelerated compute, CPUs and memory, together with rising complexity at the leading edge and in advanced packaging, continues to drive process control intensity higher. We see the pullback as a de-rating rather than a change in the earnings trajectory, and management’s commentary points to accelerating growth into 2027.

Western Digital

Western Digital detracted from performance in the third quarter despite strong fiscal fourth quarter results and a guide for continued revenue and margin expansion. Shares sold off after the August print as slowing exabyte growth and a margin outlook that trailed Seagate’s fell short of elevated expectations, and broader de-risking across memory and storage extended the decline through September.

Recent Portfolio Activity

The table below shows all buys and sells completed during the quarter, followed by a brief rationale.

BuysSells
Kratos Defense & Security SolutionsBio-Techne
RepligenMobility Global
Norfolk Southern

Buys

Kratos Defense & Security Solutions

We initiated Kratos Defense & Security Solutions, a technology-focused defense contractor that develops affordable, rapidly deployable products and platforms for government and commercial customers across satellite communications, space infrastructure, unmanned aerial systems, hypersonic technologies, rocket and propulsion systems, microwave electronics, cybersecurity, training, and command-and-control solutions. The company operates through Kratos Government Solutions and Unmanned Systems. The former provides software-defined ground systems, telemetry, tracking and control, space domain awareness, hypersonic vehicles, solid rocket motors, flight test systems, microwave electronics, and turbine technologies. The latter develops tactical aircraft, collaborative combat aircraft such as the Valkyrie and Mako platforms, and high-performance target drones for training and weapons testing. By emphasizing affordable, attritable, autonomous, software-enabled and mission-critical capabilities rather than large traditional defense platforms, we feel that Kratos is positioned to benefit from expanding defense modernization, procurement and production priorities.

Our investment case for Kratos Defense & Security Solutions is supported by a favorable defense spending environment, driven by geopolitical tensions, global modernization efforts, and rising demand for autonomous and cost-effective systems. In our view, the company is well-positioned in high-priority and rapidly growing markets, including hypersonic technologies, unmanned systems, space infrastructure and rocket propulsion, which should sustain demand despite broader budget fluctuations. Strong bookings, favorable order trends and recent program awards provide visibility into future revenue, while the transition of development programs into higher-volume production is expected to accelerate growth. As production expands, greater operating efficiency and margin improvement should support stronger earnings-per-share growth over the next several years.

Kratos Defense & Security Solutions commands a premium valuation relative to traditional defense contractors because of its strong position in rapidly expanding next-generation defense markets, substantial order backlog, favorable bookings momentum and potential for improved profitability as key programs transition into larger-scale production.

Repligen

We initiated Repligen, a global life sciences company that develops and commercializes bioprocessing technologies, systems and consumables designed to improve the efficiency, flexibility and control of biological drug manufacturing across both upstream and downstream processes. The company operates through four main franchises: filtration and fluid management, chromatography, process analytics, and proteins. Filtration and fluid management, its largest franchise, includes KrosFlo and ARTeSYN tangential flow filtration systems, TangenX flat sheet cassettes, Spectrum hollow fiber filters, membranes and modules, XCell alternating tangential flow cell retention systems, ProConnex flow path assemblies, custom single-use assemblies, components, and related consumables. The chromatography franchise primarily provides products used in downstream purification and quality control, including the OPUS prepacked chromatography column product line, while the proteins franchise supplies Protein A affinity ligands and growth factors under long-term supply agreements and through direct sales. The process analytics franchise offers SoloVPE and FlowVPX slope spectroscopy systems, consumables and services that enable in-line protein concentration measurement and real-time process management across filtration, chromatography and fill-finish applications. Filtration and fluid management generates approximately 60% of revenue, chromatography approximately 20%, and proteins and process analytics approximately 10% each, while North America accounts for about half of total company revenue.

Our investment case for Repligen is supported by an improving bioprocessing environment, including stronger biotechnology funding, growing interest in advanced therapeutic areas such as cell and gene therapies, a recovery in demand in China, and increased domestic drug manufacturing capacity in the United States. As a leading provider of specialized bioprocessing technologies and consumables, we believe the company is well-positioned to benefit from these trends through its broad portfolio and exposure to sophisticated manufacturing platforms. Continued industry recovery, stronger order momentum, portfolio diversification and operating leverage should support sustained organic revenue growth and faster adjusted earnings-per-share growth through the remainder of 2026.

We believe Repligen merits a premium valuation because it is one of the few focused bioprocessing companies and operates in an attractive life sciences market with favorable long-term growth prospects.

Sells

Bio-Techne

We sold Bio-Techne following the announcement of Merck KGaA’s agreement to acquire the company for $73 per share in cash. The offer price represented a 36% premium to the one-month volume-weighted average trading price of Bio-Techne.

Mobility Global

We sold Mobility Global. We received a small position in the stock from the spinoff from S&P Global. One of the most important assets within the company is Carfax. We are concerned that AI-enabled competitors could use the same data that is gathered and produced by Carfax to produce a competitive product. In addition, disruption in the new car production market during Covid could impact used car availability in the coming years, which could impact revenue growth opportunities at Carfax.

Norfolk Southern

We sold the position in Norfolk Southern. The current valuation is close to a multi-year high following an improvement in the freight market after three years of stagnant growth. Higher energy costs are a near-term headwind to profitability. Norfolk Southern has received a takeover offer from Union Pacific that is subject to extensive regulatory approval. The company has received requests for additional information from regulators regarding the proposed merger. The expected completion date is mid-2027, but approval remains uncertain.

Outlook

The broad equity markets posted low-single-digit returns for the quarter, with gains in Information Technology, Health Care and Energy offsetting declines in Industrials, Consumer Discretionary and Utilities. Interest rates rose sharply, with the 10-year yield up about 80 basis points for the quarter. A debate on how to regulate AI intensified as models advance toward artificial general intelligence. Several states also looked to slow development of AI projects to ensure impact on communities was controlled. Equity valuations compressed further, as earnings continue to grow at a rapid pace. The economic data points to solid economic growth, with the ISM manufacturing number well into expansion territory and employment data coming in above expectations. Geopolitical issues remain a significant overhang on the global economy, with not much progress in settling the two major conflicts. Our focus will continue to be at the company level, with an emphasis on seeking to invest in companies with secular tailwinds or strong product-driven cycles.

Disclosures

The opinions expressed herein are those of Aristotle Atlantic Partners, LLC (Aristotle Atlantic) and are subject to change without notice. Past performance is not a guarantee or indicator of future results. This material is not financial advice or an offer to purchase or sell any product. You should not assume that any of the securities transactions, sectors or holdings discussed in this report were or will be profitable, or that recommendations Aristotle Atlantic makes in the future will be profitable or equal the performance of the securities listed in this report. The portfolio characteristics shown relate to the Aristotle Atlantic Large Cap Growth strategy. Not every client’s account will have these characteristics. Aristotle Atlantic reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Atlantic’s Large Cap Growth Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. Recommendations made in the last 12 months are available upon request.

Past performance is not indicative of future results. Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. While Large-capitalization companies may have more stable prices than smaller, less established companies, they are still subject to equity securities risk. In addition, large-capitalization equity security prices may not rise as much as prices of equity securities of small-capitalization companies. Securities of small- and medium-sized companies tend to have a shorter history of operations and can be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks. The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Atlantic does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Atlantic Partners, LLC is an independent registered investment adviser under the Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Atlantic, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. AAP-2610-11

Performance Disclosure

Sources: CAPS CompositeHubTM

Past performance is not indicative of future results. Performance results for periods greater than one year have been annualized. Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

Index Disclosure

The Russell 1000® Growth Index measures the performance of the large cap growth segment of the U.S. equity universe. It includes those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values. This index has been selected as the benchmark and is used for comparison purposes only. The Russell 1000® Value Index measures the performance of the large cap value segment of the U.S. equity universe. It includes those Russell 1000 companies with lower price-to-book ratios and lower expected growth values. The Russell 2000® Index measures the performance of the small cap segment of the U.S. equity universe. The Russell 2000 Index is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2000 of the smallest securities based on a combination of their market cap and current index membership. The S&P 500® Index is the Standard & Poor’s Composite Index of 500 stocks and is a widely recognized, unmanaged index of common stock prices. The Dow Jones Industrial Average® is a price-weighted measure of 30 U.S. blue-chip companies. The Index covers all industries except transportation and utilities. The NASDAQ Composite Index measures all NASDAQ domestic and international based common type stocks listed on The NASDAQ Stock Market. The NASDAQ Composite includes over 3,000 companies, more than most other stock market indices. The Bloomberg U.S. Aggregate Bond Index is an unmanaged index of domestic investment grade bonds, including corporate, government and mortgage-backed securities. The WTI Crude Oil Index is a major trading classification of sweet light crude oil that serves as a major benchmark price for oil consumed in the United States. The 3-Month U.S. Treasury Bill is a short-term debt obligation backed by the U.S. Treasury Department with a maturity of three months. The Consumer Price Index (CPI) is a measure of the average change over time in the prices paid by urban consumers for a market basket of consumer goods and services. While stock selection is not governed by quantitative rules, a stock typically is added only if the company has an excellent reputation, demonstrates sustained growth and is of interest to a large number of investors. The volatility (beta) of the Composite may be greater or less than its respective benchmarks. It is not possible to invest directly in these indices.

(All MSCI index returns are shown net and in U.S. dollars unless otherwise noted.)

Markets Review

Sources: CAPS CompositeHubTM, Bloomberg
Past performance is not indicative of future results. Aristotle International Equity Composite returns are presented gross and net of model fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are calculated by subtracting a model fee of 0.50% on an annual basis or 0.04167% on a monthly basis, which includes trading costs and the reinvestment of all income. Please see important disclosures at the end of this document.

Shocks to energy prices stemming from renewed conflict in the Middle East, changing interest rate expectations, trade tensions, and enthusiasm (and fear) surrounding artificial intelligence (even among companies outside the United States) have become recurring themes of the market environment. Though global equity markets continue to climb, macroeconomic headlines seem to draw investors towards certain industries and away from others regardless of business fundamentals.

Brent crude, for example, started the year at roughly $60 per barrel and nearly doubled by May, then dropped back to ~$70 in July, only to spike back up above $100 later in the third quarter. Turning to central bank policy, following an unprecedented tightening cycle that concluded in 2023, the U.S. Federal Reserve cut interest rates six times in 2024 and 2025 before reversing course in the most recent quarter, joining several European central banks in raising rates. As governments in the developed world face a mix of fiscal deficits and stubborn inflation, longer-dated sovereign bond yields are climbing as well.

Against this backdrop, we believe it is particularly important to distinguish between businesses whose financial outcomes are dependent on prevailing macro conditions and those capable of succeeding across a range of environments. We recognize that “quality” is an over-used term—and often used too broadly—across the investment industry. For us, it is important to distinguish among three distinct forms of quality:

  • Transient Quality can look exceptional at the peak of a cycle, with scarcity-driven pricing power, expanding margins and high returns on capital. On the surface the economics can appear highly attractive, but when supply eventually catches up, prices normalize and investors realize what has happened, significant valuation resets can occur.
  • Conventional Quality possesses many of the characteristics traditionally associated with great businesses—powerful brands, customer loyalty, incumbency advantages and ecosystem lock-in—but the old moats are eroding. Digital advertising, ecommerce, private label, low barriers to entry and technological disruption have made certain franchises less structurally resilient than they once were.
  • Durable Quality is where we are most energized because scarcity is permanent rather than cyclical (or at least less so). These businesses can raise prices ahead of inflation for years without impairing volume, protected by natural monopolies, geology, irreplaceable infrastructure, essentiality, regulation or deliberate scarcity. Consider businesses like luxury goods manufacturers, regulated utilities and mission-critical technology solutions, or specialty data providers, unique ingredient producers and transportation platforms.

By focusing on durable quality, we seek to look beyond the whipsaw of macroeconomic events and capitalize on the disconnects they can create between share prices and long-term normalized earnings power. Importantly, we believe today’s environment continues to provide such opportunities, enabling us to selectively enhance the portfolio when we identify businesses offering a particularly compelling combination of quality, valuation and catalysts.

Performance and Attribution Summary

For the third quarter of 2026, Aristotle Capital’s International Equity Composite posted a total return of -0.87% gross of fees (-0.99% net of fees), underperforming the MSCI EAFE Index, which returned 0.81%, and the MSCI ACWI ex USA Index, which returned 0.48%. Please refer to the table below for detailed performance.

Performance (%) 3Q26YTD1 Years3 Years5 Years10 Years Since Inception*
International Equity Composite (gross)-0.874.3210.1714.706.328.396.55
International Equity Composite (net)-0.993.939.6214.145.797.866.02
MSCI EAFE Index (net)0.8110.3315.6918.409.329.074.60
MSCI ACWI ex USA Index (net)0.4814.2220.0020.549.559.254.57
*The inception date for the International Equity Composite is January 1, 2008. Past performance is not indicative of future results. Aristotle International Equity Composite returns are presented gross and net of model fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are calculated by subtracting a model fee of .50% on an annual basis or .04167% on a monthly basis, which includes trading costs and the reinvestment of all income. Please see important disclosures at the end of this document.

Source: FactSet
Past performance is not indicative of future results. Sector attribution shows how much of a portfolio’s overall return is directly attributable to stock selection and asset allocation decisions within the portfolio, highlighting which sectors contributed or detracted to the total return. Attribution includes the reinvestment of income. Attribution is presented gross of fees and does not include the deduction of all fees and expenses that a client or investor has paid or would have paid. Please refer to the gross and net composite returns included within to understand the overall impact of fees.

From a sector perspective, the portfolio’s underperformance relative to the MSCI EAFE Index can be attributed to security selection, while allocation effects contributed. Security selection in Energy, Industrials and Financials detracted most from the portfolio’s relative performance. Conversely, security selection and an underweight in Information Technology, as well as an overweight in Energy, contributed to relative returns.

Regionally, allocation effects were responsible for the portfolio’s underperformance, while security selection contributed. Exposure to Canada and Emerging Markets detracted most from relative performance, while security selection and an underweight in Europe & Middle East contributed.

Contributors and Detractors for 3Q 2026

Relative ContributorsRelative Detractors
DBS GroupBrookfield
AccentureCameco
SonySamsung Electronics
Otsuka HoldingsRentokil Initial
NemetschekFast Retailing

Relative contributors and detractors are based on attribution total effect and exclude benchmark securities not held in the portfolio.

Cameco, one of the world’s largest uranium producers, was a primary detractor during the quarter. The company’s stock sold off amid concerns that disruptions at its Canadian uranium operations (including Cigar Lake, McArthur River and Key Lake) would temporarily dampen near-term production. Despite these challenges, the company maintained its annual production outlook, while average realized prices continued to improve and long-term uranium prices reached decade highs. Cameco’s extensive use of long-term contracts, combined with the production flexibility of its tier-one assets, helps insulate the business from short-term commodity price fluctuations and operational volatility. We believe the company remains well-positioned to benefit from growing global demand for nuclear energy through its high-quality uranium assets, fuel services capabilities and ownership interest in Westinghouse.

Rentokil Initial, the U.K.-based pest control and hygiene services company, was a detractor during the quarter. Shares declined following the company’s interim results as investors focused on weaker growth in portions of its North American pest control business and management’s decision to retire its previous 2027 North American margin target. Importantly, North American organic growth improved from the prior year, while customer retention and profitability also increased. Under newly appointed CEO Mike Duffy, the company has strengthened its North American leadership team and is undertaking a broader operational restructuring, with plans to reinvest cost savings into initiatives intended to accelerate organic growth rather than maximize near-term margins. While we continue to assess the new management team’s strategy and execution, we believe Rentokil’s scale, route density and recurring service model provide the company with meaningful competitive advantages.

DBS Group, a leading Asian financial services company headquartered in Singapore, was a top contributor during the quarter. Shares rose following another strong earnings report, with record earnings supported by continued growth in wealth management and other fee-based businesses, as well as resilient net interest income despite lower local interest rates. The company continues to benefit from growing wealth creation across Asia, while its strong capital position has supported increased shareholder distributions and disciplined capital allocation. We believe DBS’s strong market position, diversified sources of earnings and disciplined capital allocation support attractive long-term returns.

Accenture, a leading technology consulting and managed services company, was a primary contributor during the quarter after being the strategy’s largest detractor during the first half of the year. Shares rallied as investor sentiment improved following significant concerns about the potential impact of artificial intelligence on traditional consulting and technology services. While market perceptions of AI’s impact on the industry have shifted considerably, our focus has remained on the underlying business and Accenture’s ability to create value for its clients. For decades, the company’s deep industry expertise, longstanding client relationships, and broad technology ecosystem positioned it to help enterprises integrate new technologies and redesign increasingly complex business processes. The latest wave of technological innovation is no different. We believe these capabilities become more valuable, rather than less, as the pace of technological change accelerates and Accenture becomes mission critical to global enterprises seeking to evolve, adapt, and grow.

Recent Portfolio Activity

BuysSells
WEGMichelin

During the quarter, we sold our position in Michelin and invested in WEG.

We initially invested in Michelin, one of the world’s largest tire manufacturers, in the first quarter of 2021. In our view, the company benefits from a strong competitive position driven by its global scale, brand strength and continued leadership in cutting-edge tire technology. During our ownership, Michelin made progress on several of the catalysts we had identified, including shifting its product mix toward higher-margin specialty and large-diameter tires, while pursuing initiatives to improve operating efficiency and expand into higher-growth businesses. However, our ongoing research, including work on Michelin’s competitors, led us to reassess some elements of our original investment thesis as competitive dynamics evolved and the opportunity for further profitability improvements became less certain. As a result, we chose to exit our position to fund what we believe is a more compelling opportunity in WEG.

WEG S.A.

Headquartered in Jaraguá do Sul, Brazil, and founded in 1961, WEG is a global electrical equipment manufacturer that has evolved from a Brazilian electric motor producer into a diversified industrial platform. The company makes equipment that helps generate, transmit, convert, control and use electricity across industrial and infrastructure applications, including motors, drives, automation systems, transformers, generators and alternators. These products serve end markets such as manufacturing, mining, oil and gas, water infrastructure, utilities, renewable energy, and data centers, giving WEG exposure to both traditional industrial demand and longer-term investment in electrification, grid modernization and automation.

WEG’s differentiation lies less in the product categories themselves than in the operating model it has built around them. Motors, transformers and other electrical equipment markets can be cyclical, competitive and capital intensive, but WEG has historically generated attractive profitability through vertical integration, engineering discipline, cost control and a long-term reinvestment culture. Its roots in southern Brazil, a region with a strong engineering and manufacturing tradition, have helped shape this operating culture. In our opinion, this model has allowed the company to expand from a strong Brazilian base into international markets while maintaining attractive returns and a strong balance sheet.

Some of the quality characteristics we have identified for WEG include:

  • A vertically integrated manufacturing model that supports cost efficiency, quality control, product customization and supply-chain reliability;
  • Significant scale and established market positions across core product categories, including global leadership in low-voltage industrial motors and a dominant position in Latin American transformers;
  • A long-term ownership culture, with the founding families retaining a controlling interest and supporting continued reinvestment in the business; and
  • A strong financial profile, including a net cash balance sheet and a long track record of growth, with only one year of negative revenue growth over the past 15 years.

Attractive Valuation

We believe shares of WEG are attractively valued given our estimates of normalized earnings. In our view, the company’s long-term opportunities for international expansion, additional manufacturing capacity and market share gains are not fully reflected in its current valuation, as investor attention remains focused on near-term uncertainty surrounding tariffs, renewable energy demand and Brazil-related macroeconomic volatility.

Compelling Catalysts   

Catalysts we have identified for WEG, which we believe will cause its stock price to appreciate over our three- to five-year investment horizon, include:

  • Continued expansion beyond Brazil, particularly in motors, transformers, alternators and automation, as WEG builds scale and market share in international markets;
  • Further localization and vertical integration of manufacturing capacity, supporting customer service, supply-chain efficiency and WEG’s ability to replicate its operating model outside of Brazil;
  • Continued integration and improvement of acquired businesses, including Marathon in motors and alternators and Crompton Greaves Power Systems in transformers, as WEG applies its manufacturing discipline and reinvestment model to these platforms; and
  • Expansion of transformer manufacturing capacity, including planned capacity additions through 2028, supported by demand for grid investment, electrification and data center-related electrical infrastructure.

Conclusion

Periods of relative underperformance can test conviction, particularly when market leadership is narrow and rapidly changing. However, we believe the appropriate response is not to chase what has recently worked but to remain focused on the long-term drivers of value creation. This discipline has guided our investment process across multiple market cycles and continues to shape how we position the portfolio today.

Importantly, recent performance has not been accompanied by a deterioration in the businesses we own. In many cases, earnings have continued to grow even as valuation multiples have compressed, creating what we believe is an increasingly attractive disconnect between share prices and normalized earnings power. While periods like this are challenging, they can also create opportunity for long-term investors. We believe the very conditions that have challenged recent relative performance have strengthened the portfolio’s prospective return potential.

Disclosures

The opinions expressed herein are those of Aristotle Capital Management, LLC (Aristotle Capital) and are subject to change without notice. Past performance is not a guarantee or indicator of future results. This material is not financial advice or an offer to buy or sell any product. You should not assume that any of the securities transactions, sectors or holdings discussed in this report were or will be profitable, or that recommendations Aristotle Capital makes in the future will be profitable or equal the performance of the securities listed in this report. The portfolio characteristics shown relate to the Aristotle International Equity strategy. Not every client’s account will have these characteristics. Aristotle Capital reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Capital’s International Equity Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection are based on the account’s period of time under management and its similarity of holdings in relation to the strategy. Recommendations made in the last 12 months are available upon request.

Past performance is not indicative of future results. Returns are presented gross and net of model fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of model fees. Net returns are calculated by subtracting a model fee of .50% on an annual basis or .04167% on a monthly basis, which includes trading costs and the reinvestment of all income.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. While Large-capitalization companies may have more stable prices than smaller, less established companies, they are still subject to equity securities risk. In addition, large-capitalization equity security prices may not rise as much as prices of equity securities of small-capitalization companies. Securities of small- and medium-sized companies tend to have a shorter history of operations and be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks. The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Capital does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Capital Management, LLC is an independent registered investment adviser under the Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Capital, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. ACM-2610-38

Performance Disclosures

Sources: CAPS CompositeHubTM, MSCI

Past performance is not indicative of future results. The information provided should not be considered financial advice or a recommendation to purchase or sell any particular security or product. Performance results for periods greater than one year have been annualized. Returns are presented gross and net of model fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of model fees. Net returns are calculated by subtracting a model fee of .50% on an annual basis or .04167% on a monthly basis, which includes trading costs and the reinvestment of all income.

Index Disclosures

The MSCI EAFE Index (Europe, Australasia, Far East) is an equity index which captures large and mid cap representation across Developed Markets (DM) countries around the world, excluding the US and Canada. The index covers approximately 85% of the free float-adjusted market capitalization in each country The MSCI ACWI Index captures large and mid cap representation across Developed Markets (DM) and Emerging Markets (EM) countries. The index covers approximately 85% of the global investable equity opportunity set. The MSCI ACWI ex USA Index captures large and mid cap representation across Developed Markets (DM) countries (excluding the US) and Emerging Markets (EM) countries. The index covers approximately 85% of the global equity opportunity set outside the United States. The MSCI Emerging Markets Index captures large and mid cap representation across Emerging Markets (EM) countries. The index covers approximately 85% of the free float-adjusted market capitalization in each country. The S&P 500 Index is the Standard & Poor’s Composite Index and is a widely recognized, unmanaged index of common stock prices. It is market cap weighted and includes 500 leading companies, capturing approximately 80% coverage of available market capitalization. The Brent Crude Oil Index is a major trading classification of sweet light crude oil that serves as a major benchmark price for purchases of oil worldwide. The Bloomberg Global Aggregate Bond Index is a flagship measure of global investment grade debt from 27 local currency markets. This multi-currency benchmark includes treasury, government-related, corporate and securitized fixed-rate bonds from both developed and emerging markets issuers. The MSCI Europe Index captures large and mid cap representation across Developed Markets (DM) countries in Europe. The Index covers approximately 85% of the free float-adjusted market capitalization across the European Developed Markets equity universe. These indexes have been selected as the benchmarks and are used for comparison purposes only. The volatility (beta) of the Composite may be greater or less than the respective benchmarks. It is not possible to invest directly in these indexes.

For more on International Equity, access the latest resources.

Markets Review

The U.S. equity market advanced during the third quarter of 2026, with the S&P 500 Index rising 2.30% despite heightened geopolitical uncertainty and rising interest rates. In contrast, fixed income markets weakened as rising Treasury yields pressured prices, with the Bloomberg U.S. Aggregate Bond Index declining 3.51%.

On a sector basis, seven of the eleven sectors within the S&P 500 Index posted declines during the quarter, highlighting the narrow breadth of the market’s advance. The strongest-performing sectors were Energy and Information Technology, supported by higher energy prices and continued AI-related investment, respectively. The weakest sectors were Utilities and Industrials.

Sources: CAPS CompositeHubTM, Bloomberg
Past performance is not indicative of future results. Aristotle Atlantic Core Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Please see important disclosures at the end of this document.

Market leadership remained concentrated in a relatively narrow group of companies, with gains in the S&P 500 Index driven by continued enthusiasm surrounding artificial intelligence and related capital investment. Leadership shifted within technology, as software stocks recovered from earlier weakness while semiconductors pulled back following the second quarter rally.

Geopolitical uncertainty remained elevated as U.S.-Iran negotiations stalled and renewed hostilities disrupted energy supplies and shipping in the Middle East. Oil and refined-product prices rose sharply, with diesel markets particularly constrained. Disruptions to Russian refining capacity added to supply pressures as the conflict in Ukraine remained volatile, reinforcing concerns surrounding global energy availability and inflation.

Inflation remained elevated, with the CPI rising 3.4% year-over-year in August as gasoline prices accounted for more than one-third of the monthly increase. Against the backdrop of resilient consumer spending and economic growth, the Federal Reserve raised its federal funds target range by 0.25 percentage points to 3.75%-4.00% in September, marking a stark reversal from expectations for multiple rate cuts at the beginning of the year.

Performance and Attribution Summary

For the third quarter of 2026, Aristotle Atlantic’s Core Equity Composite posted a total return of 4.82% gross of fees (4.72% net of fees), outperforming the S&P 500 Index, which recorded a total return of 2.30%.

Performance (%)QTDYTD1 Year3 Years5 Years10 YearsSince Inception*
Core Equity Composite (gross)4.8215.1518.9725.3913.3016.0515.06
Core Equity Composite (net)4.7214.7918.4824.8812.8315.5814.54
S&P 500 Index2.3012.7515.7422.8913.7915.3314.18
*The Core Equity Composite has an inception date of August 1, 2013 at a predecessor firm. During this time, Mr. Fitzpatrick had primary responsibility for managing the strategy. Performance starting November 1, 2016 was achieved at Aristotle Atlantic. Past performance is not indicative of future results. Aristotle Atlantic Core Equity Composite returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses. Please see important disclosures at the end of this document.

Source: FactSet
Past performance is not indicative of future results. Sector attribution shows how much of a portfolio’s overall return is directly attributable to stock selection and asset allocation decisions within the portfolio, highlighting which sectors contributed or detracted to the total return. Attribution includes the reinvestment of income. Attribution is presented gross of fees and does not include the deduction of all fees and expenses that a client or investor has paid or would have paid. Please refer to the gross and net composite returns included within to understand the overall impact of fees. Please see important disclosures at the end of this document.

During the third quarter, the portfolio’s outperformance compared to the S&P 500 Index was due to security selection. Selection in Health Care and Financials contributed the most to relative performance. Conversely, security selection in Energy and Information Technology detracted the most from relative performance.

Contributors and Detractors for 3Q 2026

Relative ContributorsRelative Detractors
Adaptive BiotechnologiesApplied Materials
Guardant HealthCoherent
DexcomApple
CrowdStrike HoldingsTrane Technologies
Meta PlatformsGE Aerospace

Relative contributors and detractors are based on attribution total effect and exclude benchmark securities not held in the portfolio.

Contributors

Adaptive Biotechnologies

Adaptive Biotechnologies contributed to performance in the quarter following second quarter earnings where the company beat consensus estimates and raised full-year revenue guidance on the back of strong clonoSEQ volume and rising average selling prices. Investor sentiment rose following Adaptive’s announcement of plans to separate its Immune Medicine business; this will result in a standalone Minimal Residual Disease diagnostic company.

Guardant Health

Guardant Health contributed to performance in the quarter after the company announced second quarter earnings that showed 44% year-over-year revenue growth, fueled by 63% growth in clinical oncology volumes. Furthermore, Guardant announced that its non-invasive colorectal cancer screening test, Guardant Shield, won a pivotal coverage decision from UnitedHealth Group, one of the largest commercial insurers, leading to coverage in patients under the age of 65 not on Medicare. Later in the quarter, Guardant announced additional commercial coverage. The FDA also approved a higher-throughput, lower cost-of-goods-sold workflow for Shield, which will result in higher margins as the product scales. Guardant is seeing strong volume growth momentum across its diverse product offerings.

Detractors

Applied Materials

Applied Materials detracted from performance in the third quarter despite reporting record fiscal third quarter results and raising its outlook. Shares sold off following the mid-August print as investors focused on a flat sequential gross margin guide and China’s declining share of the revenue mix, and the selling broadened through the remainder of August as growing scrutiny of AI infrastructure financing drove a repricing across the wafer fab equipment group. The stock recovered some ground in September alongside a broader semiconductor rebound but ended the quarter below pre-earnings levels. The company remains structurally leveraged to the AI buildout, as continued investment in AI compute requires greater silicon intensity across accelerated compute (GPUs/ASICs), CPUs and memory (DRAM/NAND), and Applied Materials remains a leader in front-end wafer fabrication and packaging equipment. With the stock still up substantially year to date, we see the third quarter pullback as a de-rating rather than a change in the earnings trajectory and continue to expect a multi-year acceleration in top-line growth.

Coherent

Coherent detracted from performance in the third quarter as investors rotated out of AI infrastructure names on concerns that data center capacity is being overbuilt and that lower-cost Chinese open-source models will force frontier labs to cut token pricing, compressing margins and the capital available to fund frontier model development. Record fiscal fourth quarter results were not enough to offset the de-rating. The company remains structurally levered to the AI infrastructure buildout, as next-generation data center architectures require increasing optical connectivity, both intra-rack and inter-data center, to meet rising compute and power-efficiency demands. We view the quarter’s selloff as a healthy correction following Coherent’s strong run, and we continue to expect multi-year acceleration in top-line growth alongside sustained gross margin expansion.

Recent Portfolio Activity

The table below shows all buys and sells completed during the quarter, followed by a brief rationale.

BuysSells
SanDiskHoneywell Aerospace
Honeywell International

Buys

SanDisk

We initiated SanDisk as a complementary picks-and-shovels investment opportunity tied to the AI memory bottleneck, with NAND flash memory and solid-state storage now capacity-constrained inputs for AI data center expansion. These components are shifting away from commoditized consumer technology inputs, and we believe SanDisk can benefit from stronger pricing power, multi-year customer agreements, higher earnings and potential valuation multiple expansion.

SanDisk is a global developer and manufacturer of flash memory storage solutions headquartered in Milpitas, California, following its spinoff from Western Digital in February 2025. The company serves enterprise data centers, personal computers, smartphones and consumer devices through products including enterprise solid-state drives, client solid-state drives, embedded mobile storage, and branded removable and retail storage. SanDisk manufactures through its Flash Ventures joint venture with Kioxia, giving it access to advanced three-dimensional flash memory production at low-cost, capital-efficient economics, while retaining vertical integration in controller and firmware intellectual property, supported by a large patent portfolio. The company is increasingly focused on higher-value storage demand tied to AI data center growth.

In our view, SanDisk offers an attractive investment opportunity because the rapid expansion of AI, cloud computing and data-intensive applications is increasing demand for high-capacity flash storage across data centers, consumer devices and enterprise systems. Long-term customer agreements can improve revenue visibility, while disciplined industry supply and the company’s lower-cost manufacturing partnership may support stronger pricing, higher factory utilization and more durable profit margins than in prior memory cycles. As a focused standalone company, SanDisk can direct capital toward its highest-return storage opportunities, including high-bandwidth flash products designed for AI workloads. Its debt-free balance sheet and capacity to return cash to shareholders can provide additional financial flexibility, while a geographically diversified production network strengthens supply resilience and competitive positioning. The investment case depends on continued storage demand, rational industry capacity additions, successful product execution and protection against risks such as pricing volatility, customer concentration, technological disruption and manufacturing interruptions.

SanDisk appears attractively valued relative to its trading history, as the market may not fully appreciate the company’s improving earnings outlook and the structural benefits of stronger AI storage demand, disciplined industry supply, contracted customer demand and favorable pricing. These factors should reduce earnings volatility, strengthen performance across industry cycles and support a higher valuation over time.

Sells

Honeywell Aerospace

We sold the position in Honeywell Aerospace to consolidate our aerospace investment in GE Aerospace. Although the company should benefit from increases in aircraft production rates, organic revenue growth at Honeywell Aerospace is slower than the aerospace and defense peer group. Investment in R&D will likely be required to regain lost market share in commercial aerospace.

Honeywell International

We sold the position in Honeywell International. Following the spinoff of the aerospace business and various other simplification efforts over the past few years, the company remains a complex investment case. Near-term investment catalysts are difficult to identify. The consensus earnings growth expectations, which are in the mid- to high teens over the next couple of years, seem aggressive compared to the company’s history.

Outlook

The broad equity markets posted low-single-digit returns for the quarter, with gains in Information Technology, Health Care and Energy offsetting declines in Industrials, Consumer Discretionary and Utilities. Interest rates rose sharply, with the 10-year yield up about 85 basis points for the quarter. A debate on how to regulate AI intensified as models advance toward artificial general intelligence. Several states also looked to slow development of AI projects to ensure impact on communities was controlled. Equity valuations compressed further, as earnings continue to grow at a rapid pace. The economic data points to solid economic growth, with the ISM manufacturing number well into expansion territory and employment data coming in above expectations. Geopolitical issues remain a significant overhang on the global economy, with not much progress in settling the two major conflicts. Our focus will continue to be at the company level, with an emphasis on seeking to invest in companies with secular tailwinds or strong product-driven cycles.

Disclosures

The opinions expressed herein are those of Aristotle Atlantic Partners, LLC (Aristotle Atlantic) and are subject to change without notice. Past performance is not a guarantee or indicator of future results. This material is not financial advice or an offer to purchase or sell any product. You should not assume that any of the securities transactions, sectors or holdings discussed in this report were or will be profitable, or that recommendations Aristotle Atlantic makes in the future will be profitable or equal the performance of the securities listed in this report. The portfolio characteristics shown relate to the Aristotle Atlantic Core Equity strategy. Not every client’s account will have these characteristics. Aristotle Atlantic reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased. The securities discussed may not represent an account’s entire portfolio and, in the aggregate, may represent only a small percentage of an account’s portfolio holdings. The performance attribution presented is of a representative account from Aristotle Atlantic’s Core Equity Composite. The representative account is a discretionary client account which was chosen to most closely reflect the investment style of the strategy. The criteria used for representative account selection is based on the account’s period of time under management and its similarity of holdings in relation to the strategy. Recommendations made in the last 12 months are available upon request.

Past performance is not indicative of future results. Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

All investments carry a certain degree of risk, including the possible loss of principal. Investments are also subject to political, market, currency and regulatory risks or economic developments. International investments involve special risks that may in particular cause a loss in principal, including currency fluctuation, lower liquidity, different accounting methods and economic and political systems, and higher transaction costs. These risks typically are greater in emerging markets. While Large-capitalization companies may have more stable prices than smaller, less established companies, they are still subject to equity securities risk. In addition, large-capitalization equity security prices may not rise as much as prices of equity securities of small-capitalization companies. Securities of small- and medium-sized companies tend to have a shorter history of operations, be more volatile and less liquid. Value stocks can perform differently from the market as a whole and other types of stocks. The material is provided for informational and/or educational purposes only and is not intended to be and should not be construed as investment, legal or tax advice and/or a legal opinion. Investors should consult their financial and tax adviser before making investments. The opinions referenced are as of the date of publication, may be modified due to changes in the market or economic conditions, and may not necessarily come to pass. Information and data presented has been developed internally and/or obtained from sources believed to be reliable. Aristotle Atlantic does not guarantee the accuracy, adequacy or completeness of such information.

Aristotle Atlantic Partners, LLC is an independent registered investment adviser under the Advisers Act of 1940, as amended. Registration does not imply a certain level of skill or training. More information about Aristotle Atlantic, including our investment strategies, fees and objectives, can be found in our Form ADV Part 2, which is available upon request. AAP-2610-10

Performance Disclosures

Sources: CAPS CompositeHubTM

The Aristotle Core Equity Composite has an inception date of August 1, 2013 at a predecessor firm. During this time, Mr. Fitzpatrick had primary responsibility for managing the strategy. Performance starting November 1, 2016 was achieved at Aristotle Atlantic.

Past performance is not indicative of future results. Performance results for periods greater than one year have been annualized. Returns are presented gross and net of investment advisory fees and include the reinvestment of all income. Gross returns will be reduced by fees and other expenses that may be incurred in the management of the account. Net returns are presented net of actual investment advisory fees and after the deduction of all trading expenses.

Index Disclosures

The Russell 1000® Growth Index measures the performance of the large cap growth segment of the U.S. equity universe. It includes those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values. The Russell 1000® Value Index measures the performance of the large cap value segment of the U.S. equity universe. It includes those Russell 1000 companies with lower price-to-book ratios and lower expected growth values. The S&P 500® Index is the Standard & Poor’s Composite Index of 500 stocks and is a widely recognized, unmanaged index of common stock prices. This index has been selected as the benchmark and is used for comparison purposes only. The Dow Jones Industrial Average® is a price-weighted measure of 30 U.S. blue-chip companies. The Index covers all industries except transportation and utilities. The NASDAQ Composite Index measures all NASDAQ domestic and international based common type stocks listed on The NASDAQ Stock Market. The NASDAQ Composite includes over 3,000 companies, more than most other stock market indices. The Bloomberg U.S. Aggregate Bond Index is an unmanaged index of domestic investment grade bonds, including corporate, government and mortgage-backed securities. The WTI Crude Oil Index is a major trading classification of sweet light crude oil that serves as a major benchmark price for oil consumed in the United States. The Russell 2000® Index measures the performance of the small cap segment of the U.S. equity universe. The Russell 2000 Index is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2000 of the smallest securities based on a combination of their market cap and current index membership. The 3-Month U.S. Treasury Bill is a short-term debt obligation backed by the U.S. Treasury Department with a maturity of three months. The Consumer Price Index (CPI) is a measure of the average change over time in the prices paid by urban consumers for a market basket of consumer goods and services. While stock selection is not governed by quantitative rules, a stock typically is added only if the company has an excellent reputation, demonstrates sustained growth and is of interest to a large number of investors. The volatility (beta) of the Composite may be greater or less than its respective benchmarks. It is not possible to invest directly in these indices.